健倍苗苗(02161)周一盘中大涨5.34%,引起市场广泛关注。
消息面上,雅各臣科研制药(02633)发布盈喜公告,预期截至2024年9月30日止6个月来自持续经营业务的溢利较去年同期增加超过40%。盈利大幅增加主要是由于公私营界别非专利药业务的稳健业绩,以及新获授权产品和新产品强劲推出所带来的收益贡献等因素所致。
由于在实物分派健倍苗苗股份作为特别股息后,雅各臣科研制药不再将健倍苗苗及其附属公司业绩并入财务报表。但预期中期期间雅各臣科研制药权益持有人应占溢利只会轻微下降不超过9%,意味着健倍苗苗自身业绩也在改善。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.